Skip to content
Cerevention
  • Products
    • MindsEye™ Expandable Port
    • Neurapheresis™ CSF Management System
    • DepiCT™ Neuroimaging Platform
  • Company
    • News
  • Contact

News

September 9, 2020 | News

Minnetronix Medical Gets FDA Clearance on Innovative Neurosurgical Access Platform

Medical technology company expands on 25 years of experience with new portfolio of neuro devices, including expandable port for deep brain access.

Read Article
June 29, 2019 | News

Impact of Cerebrospinal Fluid Filtration on Subarachnoid Hemorrhage Clearance: A Computational Fluid Dynamics Study

June 25, 2019 – Mohammadreza Khani, Lucas R. Sass, et al Summer Biomechanics, Bioengineering, and Biotransport Conference, Seven Springs, PennsylvaniaMohammadreza…

Read Article
June 25, 2019 | News

In Vitro Anthropomorphic Model of the Cerebrospinal Fluid System: Application to Subarachnoid Hemorrhage Filtration

June 25, 2019 – Summer Biomechanics, Bioengineering, and Biotransport Conference, Seven Springs, Pennsylvania – Lucas R. Sass, Mohammadreza Khani, et…

Read Article
April 13, 2019 | News

Healthcare Economics of Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage in the United States

April 13, 2019 – American Association of Neurological Surgeons, San Diego, CA, Syed M. Adil, Beiyu Liu, et al Syed…

Read Article
March 13, 2019 | News

Healthcare Economics of Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage in the United States

March 13, 2019 – Translational Stroke Research, Syed M. Adil, Beiyu Liu, et al Abstract – Hydrocephalus is one of…

Read Article
  • «
  • 1
  • 2
  • 3
  • 4
  • »

Cerevention
1635 Energy Park Drive
St. Paul, MN 55108
P: 651-917-4060
info@cerevention.com

Minnetronix is a trademark of Minnetronix Medical, Inc. MindsEye is a trademark of Minnetronix Neuro, Inc. Cerevention is a trademark of Minnetronix Neuro, Inc.
Caution: Federal (U.S.A.) Law restricts this device to sale by or on the order of a physician.

Neurapheresis is a trademark of Minnetronix Neuro, Inc.
Caution: Investigational Device. Limited by Federal (U.S.A.) law to investigational use only.

DepiCT is a trademark of Minnetronix Neuro, Inc.
DepiCT Neuroimaging Platform is currently under development. All subsequent material represents intended use.

LinkedIn Facebook Twitter Twitter
© 2023 Minnetronix Neuro. All rights reserved.